Cited in boardrooms, legal proceedings & government briefings since 2017
Medical cannabis is legal in Poland and adult-use is illegal. Below: a free market overview, with the full sizing, regulation and trade data available from PP.
Medical cannabis sales and registered patients in Poland, 2025 actuals and the 2027 forecast. Forecasts to 2030 are in the Poland data pack.
Medical sales, EUR
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| Medical sales | €57.8m | €70.5m | €79.6m | |||
| Patients | 95,333 | 116,317 | 131,362 |
Forecasts to 2030 — sales, patients and the full Poland series — are in the Poland data pack, or scoped to your question in a bespoke brief.
See the data pack Request a briefSource: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025)
The full data appendix behind the Poland market update — monthly, quarterly and annual dispensing volumes, prescriptions, sales and pricing since 2019, plus Bear/Base/Bull forecast scenarios to 2027 across 5 sections, updated each edition.
Annual flower dispensed (kg)
Medical cannabis flower dispensed, kg — 2019–2024 actuals
Source: Centrum e-Zdrowia reimbursement data; EUR converted at ECB monthly average PLN/EUR rates. Actuals to 2025 and the model forecast to 2027 are included in the full dataset.
Quarterly series, Q1 2019 – Q4 2025
28 quarters × 6 metrics
In the full dataset
Monthly series, Jan 2019 – Dec 2025
84 months × 4 metrics
In the full dataset
2026–2027 forecast — Bear / Base / Bull scenarios
3 scenarios × 2 forecast years
In the full dataset
Annual average PLN/EUR exchange rate
7 years
In the full dataset
The full Poland deep dataset — monthly, quarterly and annual dispensing volumes, prescriptions, sales and pricing since 2019, plus Bear/Base/Bull forecast scenarios to 2027 across 5 sections, with CSV export — is sold as a one-off data pack.
Buy the Poland datasetFebruary 2026 (v1.0) edition.
How Poland’s framework got here, and what moves next.
Medical cannabis legalised
Poland legalises medical cannabis under the Law on Preventing Narcotics Addiction, with a restrictive framework for commercial activity.
Telemedicine prescribing tightened
New Ministry of Health rules end the rapid-prescription telemedicine model that had driven much of the market's early growth.
Recovery on a regulated footing
The market stabilises after the telemedicine correction; PP tracks the recovery in the Poland deep dataset.
From International Cannabis Weekly, our free global briefing.
HempToday · №444 · 10 Apr 2026 · Hemp & CBD
HempToday · №442 · 20 Mar 2026 · Events & Industry
Business of Cannabis · №439 · 27 Feb 2026 · Medical
Business of Cannabis · №438 · 20 Feb 2026 · Medical
№410 · 25 Jul 2025 · Regulation
№406 · 27 Jun 2025 · Business & Investment
Poland’s estimated medical cannabis market size for 2025 is over €45 million.
Poland’s legalised medical cannabis in 2017 and its regulatory framework is restrictive in terms of commercial activity. Typically, medical cannabis products undergo a lengthy and bureaucratic authorisation process, which has delayed products entering the market and caused supply chain issues in its founding years. Since 2022, the country permitted the commercial cultivation of medical cannabis through special permits. However, no cultivation activities have yet begun.
Poland’s medical cannabis market saw significant growth from 2022 to the end of 2024 due to several factors including: a rise in product authorisations, stronger import/distribution supply chains, a reduction in the price of products, increased awareness of medical cannabis by healthcare professionals and the rise of telemedicine. However, in November 2024 Poland’s Ministry of Health restricted the use of online consultations for medical cannabis. The new rules require prescribers to conduct initial examinations in person, allowing the use of remote consultations only after an initial examination has been conducted in person.
Poland remains an import-reliant market. A small amount of imported products are re-exported, however there is no domestic production industry for medical cannabis in the country.
In the full Poland market data
Sizing, forecasts, pricing, trade flows and licensed operators — verified by PP’s analysts. Available as a data pack.
